PineBridge Investments’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-100
Closed -$4.94K 703
2023
Q2
$4.94K Hold
100
﹤0.01% 864
2023
Q1
$4.14K Hold
100
﹤0.01% 728
2022
Q4
$4.44K Hold
100
﹤0.01% 711
2022
Q3
$4K Hold
100
﹤0.01% 714
2022
Q2
$4K Hold
100
﹤0.01% 710
2022
Q1
$7K Sell
100
-700
-88% -$45.4K ﹤0.01% 660
2021
Q4
$56K Buy
+800
New +$58.1K ﹤0.01% 695

Other funds holding ATRC

PineBridge Investments's ATRC Position: Q3 2023 in Review

PineBridge Investments sold out of AtriCure (ATRC) in Q3 2023, closing a stake of 100 shares — an estimated $4.94K sold.

PineBridge Investments first reported a position in ATRC in Q4 2021 and held it in 7 quarters. The position peaked at $56K in Q4 2021. 230 funds tracked by Wall St. Rank hold ATRC as of Q3 2023.

  • PineBridge Investments reported no remaining AtriCure position as of Q3 2023 after selling out during the quarter.
  • PineBridge Investments sold 100 AtriCure shares in Q3 2023, an estimated $4.94K.
  • PineBridge Investments first reported a position in AtriCure in Q4 2021 and held it in 7 quarters.
  • PineBridge Investments's AtriCure position peaked at $56K in Q4 2021.
  • 230 funds tracked by Wall St. Rank held AtriCure as of Q3 2023.

Based on PineBridge Investments's 13F filing for Q3 2023, filed 14 Nov 2023.